These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1502384)

  • 21. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 22. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
    Haase R; Jaspers C; Schulte HM; Lancranja I; Pfingsten H; Orri-Fend M; Reinwein D; Benker G
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
    Kamel N; Uysal AR; Cesur V; Erdoğan G; Başkal N
    Endocr J; 1995 Aug; 42(4):581-6. PubMed ID: 8556068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine.
    Merola B; Sarnacchiaro F; Colao A; Di Somma C; Di Sarno A; Ferone D; Selleri A; Landi ML; Schettini G; Nappi C
    Gynecol Endocrinol; 1994 Sep; 8(3):175-81. PubMed ID: 7847102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine for prolactinoma-related dissociative disorder and depression.
    Cohen AJ
    J Clin Psychopharmacol; 1995 Apr; 15(2):144-5. PubMed ID: 7782492
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shrinkage of pituitary PRL-secernent adenoma after short-term treatment with bromocriptine long-acting repeatable injections.
    Paoletti AM; Cagnacci A; Mais V; Ajossa S; Guerriero S; Murgia C; Depau GF; Serra GG; Melis GB
    Clin Exp Obstet Gynecol; 1994; 21(2):124-8. PubMed ID: 8070116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term bromocriptine treatment of giant prolactinoma: report of a case].
    Mashio Y; Beniko M; Ikota A; Mizumoto H; Sato S; Yamaguchi O; Suzuki S; Tashiro T; Ikota T
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1785-6. PubMed ID: 2625603
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of macroprolactinomas with delayed bromocriptine. Effectiveness of a single intramuscular injection].
    García-Luna PP; Leal-Cerro A; Pereira JL; Navarro E; Trujillo F; Cortés A; Villamil F; Acosta D; Santos C; Revuelta M
    Med Clin (Barc); 1990 Feb; 94(4):126-9. PubMed ID: 2325463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of primary treatment with bromocriptine of prolactinomas with extrasellar extension.
    van 't Verlaat JW; Croughs RJ; Hendriks MJ; Bosma NJ
    Can J Neurol Sci; 1990 Feb; 17(1):71-3. PubMed ID: 2311021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 32. [Macroprolactinoma reduction and pregnancy induction with bromocriptine].
    Grimaldo J; López Espinoza E; Villanueva C; Verulo Reyes TB; Ayala AR
    Ginecol Obstet Mex; 1988 Aug; 56():213-7. PubMed ID: 3154241
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
    Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
    Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When to discontinue treatment of prolactinoma?
    Wass JA
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):298-9. PubMed ID: 16932302
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of bromocriptine in the treatment of macroprolactinomas.
    Essaïs O; Bouguerra R; Hamzaoui J; Marrakchi Z; Hadjri S; Chamakhi S; Zidi B; Ben Slama C
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):524-31. PubMed ID: 12527854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
    Galvan G; Frick J; Irnberger T
    Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.
    Chattopadhyay A; Bhansali A; Masoodi SR
    Pituitary; 2005; 8(2):147-54. PubMed ID: 16379032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte abnormalities in patients with macro- and micro-prolactinoma: different effects of bromocriptine treatment in the two groups.
    De Bernardi B; Scorza R; Hu C; Travaglini P; Della Casa Alberighi O; Togni ME; Honorati C; Cigognini A
    Int J Neurosci; 1990 Apr; 51(3-4):261-3. PubMed ID: 2279881
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic treatment with parlodel LAR of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas.
    Maraschini C; Moro M; Masala A; Toja P; Alagna S; Brunani A; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):494-501. PubMed ID: 1759539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
    Lesser RL; Zheutlin JD; Boghen D; Odel JG; Robbins RJ
    Am J Ophthalmol; 1990 May; 109(5):535-43. PubMed ID: 2333917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.